Melicent Peck, MD, PhD

Title(s)Attending Physician, Medicine
SchoolSchool of Medicine
Address400 Parnassus Avenue
San Francisco CA 94117
Phone650-353-2626
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, BerkeleyBA, BSBiochemistry
    Stanford UniversityPh.D.2002Biological Sciences
    Stanford UniversityM.D.2007Medicine
    Stanford UniversityResidency2010Internal Medicine
    UCSFFellowship2013Infectious Diseases
    UCSFCertificate in Clinical Research2014Epidemiology and Biostatistics
    Collapse Awards and Honors
    2014CROI Young Investigator Award

    Collapse Overview 
    Collapse Overview
    Melicent Peck is a board-certified infectious diseases physician. She completed her MD/PhD training and internal medicine residency at Stanford University, infectious diseases fellowship at UCSF, and the Advanced Training in Clinical Research certificate at UCSF. She currently leads the early clinical development of novel antibiotics against multi-drug resistant bacteria and contributes to strategies to ensure that new antibiotics reach patients. She also leads the early clinical development of new immunotherapies. She is an attending physician at the UCSF Infectious Diseases Clinic.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection. Open Forum Infect Dis. 2022 Feb; 9(2):ofab630. Lim JJ, Dar S, Venter D, Horcajada JP, Kulkarni P, Nguyen A, McBride JM, Deng R, Galanter J, Chu T, Newton EM, Tavel JA, Peck MC. PMID: 35106315; PMCID: PMC8801227.
      View in: PubMed   Mentions:
    2. Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A Infection. J Clin Pharmacol. 2020 11; 60(11):1509-1518. Deng R, She G, Maia M, Lim JJ, Peck MC, McBride JM, Kulkarni P, Horn P, Castro A, Newton E, Tavel JA, Hanley WD. PMID: 32621543; PMCID: PMC7586956.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    3. A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of MHAA4549A, a Monoclonal Antibody, plus Oseltamivir in Patients Hospitalized with Severe Influenza A Virus Infection. Antimicrob Agents Chemother. 2020 06 23; 64(7). Lim JJ, Nilsson AC, Silverman M, Assy N, Kulkarni P, McBride JM, Deng R, Li C, Yang X, Nguyen A, Horn P, Maia M, Castro A, Peck MC, Galanter J, Chu T, Newton EM, Tavel JA. PMID: 32393496; PMCID: PMC7318030.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    4. Risk stratification biomarkers for Staphylococcus aureus bacteraemia. Clin Transl Immunology. 2020; 9(2):e1110. Cao Y, Guimaraes AO, Peck MC, Mayba O, Ruffin F, Hong K, Carrasco-Triguero M, Fowler VG, Maskarinec SA, Rosenberger CM. PMID: 32082571; PMCID: PMC7018520.
      View in: PubMed   Mentions: 2  
    5. A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-Staphylococcus aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers. Antimicrob Agents Chemother. 2019 06; 63(6). Peck M, Rothenberg ME, Deng R, Lewin-Koh N, She G, Kamath AV, Carrasco-Triguero M, Saad O, Castro A, Teufel L, Dickerson DS, Leonardelli M, Tavel JA. PMID: 30910894; PMCID: PMC6535527.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    6. A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection. Clin Infect Dis. 2019 04 24; 68(9):1502-1511. Guimaraes AO, Cao Y, Hong K, Mayba O, Peck MC, Gutierrez J, Ruffin F, Carrasco-Triguero M, Dinoso JB, Clemenzi-Allen A, Koss CA, Maskarinec SA, Chambers HF, Fowler VG, Baruch A, Rosenberger CM. PMID: 30165412; PMCID: PMC6481998.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    7. Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia. Open Forum Infect Dis. 2019 Apr; 6(4):ofz126. Guimaraes AO, Gutierrez J, Maskarinec SA, Cao Y, Hong K, Ruffin F, Carrasco-Triguero M, Peck MC, Fowler VG, Baruch A, Rosenberger CM. PMID: 31041341; PMCID: PMC6483138.
      View in: PubMed   Mentions: 2  
    8. Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Staphylococcus aureus Bacteremia. Open Forum Infect Dis. 2019 Apr; 6(4):ofz090. Gutierrez J, Guimaraes AO, Lewin-Koh N, Berhanu A, Xu M, Cao Y, Kim J, Yan D, Chang JK, Dinoso JB, Koss CA, Clemenzi-Allen A, Chambers HF, Peck MC, Baruch A, Rosenberger CM. PMID: 31024970; PMCID: PMC6475589.
      View in: PubMed   Mentions: 3  
    9. Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals. PLoS Pathog. 2014 Aug; 10(8):e1004345. Klatt NR, Bosinger SE, Peck M, Richert-Spuhler LE, Heigele A, Gile JP, Patel N, Taaffe J, Julg B, Camerini D, Torti C, Martin JN, Deeks SG, Sinclair E, Hecht FM, Lederman MM, Paiardini M, Kirchhoff F, Brenchley JM, Hunt PW, Silvestri G. PMID: 25167059; PMCID: PMC4148445.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    10. Isolation and characterization of mutant Sinorhizobium meliloti NodD1 proteins with altered responses to luteolin. J Bacteriol. 2013 Aug; 195(16):3714-23. Peck MC, Fisher RF, Bliss R, Long SR. PMID: 23772067; PMCID: PMC3754574.
      View in: PubMed   Mentions: 6     Fields:    Translation:Cells
    11. Diverse flavonoids stimulate NodD1 binding to nod gene promoters in Sinorhizobium meliloti. J Bacteriol. 2006 Aug; 188(15):5417-27. Peck MC, Fisher RF, Long SR. PMID: 16855231; PMCID: PMC1540014.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    12. The RNA polymerase alpha subunit from Sinorhizobium meliloti can assemble with RNA polymerase subunits from Escherichia coli and function in basal and activated transcription both in vivo and in vitro. J Bacteriol. 2002 Jul; 184(14):3808-14. Peck MC, Gaal T, Fisher RF, Gourse RL, Long SR. PMID: 12081950; PMCID: PMC135166.
      View in: PubMed   Mentions: 4     Fields:    Translation:Cells
    13. Luteolin and GroESL modulate in vitro activity of NodD. J Bacteriol. 2002 Jan; 184(2):525-30. Yeh KC, Peck MC, Long SR. PMID: 11751831; PMCID: PMC139556.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    14. Nucleotide sequence and predicted functions of the entire Sinorhizobium meliloti pSymA megaplasmid. Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9883-8. Barnett MJ, Fisher RF, Jones T, Komp C, Abola AP, Barloy-Hubler F, Bowser L, Capela D, Galibert F, Gouzy J, Gurjal M, Hong A, Huizar L, Hyman RW, Kahn D, Kahn ML, Kalman S, Keating DH, Palm C, Peck MC, Surzycki R, Wells DH, Yeh KC, Davis RW, Federspiel NA, Long SR. PMID: 11481432; PMCID: PMC55547.
      View in: PubMed   Mentions: 105     Fields:    Translation:Cells
    15. The composite genome of the legume symbiont Sinorhizobium meliloti. Science. 2001 Jul 27; 293(5530):668-72. Galibert F, Finan TM, Long SR, Puhler A, Abola P, Ampe F, Barloy-Hubler F, Barnett MJ, Becker A, Boistard P, Bothe G, Boutry M, Bowser L, Buhrmester J, Cadieu E, Capela D, Chain P, Cowie A, Davis RW, Dreano S, Federspiel NA, Fisher RF, Gloux S, Godrie T, Goffeau A, Golding B, Gouzy J, Gurjal M, Hernandez-Lucas I, Hong A, Huizar L, Hyman RW, Jones T, Kahn D, Kahn ML, Kalman S, Keating DH, Kiss E, Komp C, Lelaure V, Masuy D, Palm C, Peck MC, Pohl TM, Portetelle D, Purnelle B, Ramsperger U, Surzycki R, Thebault P, Vandenbol M, Vorholter FJ, Weidner S, Wells DH, Wong K, Yeh KC, Batut J. PMID: 11474104.
      View in: PubMed   Mentions: 438     Fields:    Translation:AnimalsCells
    Melicent's Networks
    Concepts (105)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California